Publication: Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer
No Thumbnail Available
Open/View Files
Date
2009
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Nature
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Ng, K, B M Wolpin, J A Meyerhardt, K Wu, A T Chan, B W Hollis, E L Giovannucci, M J Stampfer, W C Willett, and C S Fuchs. 2009. “Prospective Study of Predictors of Vitamin D Status and Survival in Patients with Colorectal Cancer.” British Journal of Cancer 101 (6): 916–23. https://doi.org/10.1038/sj.bjc.6605262.
Research Data
Abstract
BACKGROUND: In an earlier study, a 25-hydroxyvitamin D(3) (25(OH) D) score calculated from known predictors of vitamin D status significantly predicted plasma levels of 25(OH) D and the risk of colorectal cancer, but the influence of the 25(OH) D score on survival after diagnosis is unknown. MATERIALS AND METHODS: We prospectively examined the influence of post-diagnosis predicted 25(OH) D levels on mortality among 1017 participants in the Nurses' Health Study and Health Professionals Follow-Up Study who were diagnosed with colorectal cancer from 1986 to 2004. Colorectal cancer-specific and overall mortality according to quintiles of predicted 25(OH) D levels were assessed. Cox proportional hazards models were used to calculate hazard ratios (HRs) adjusted for other risk factors of survival. RESULTS: Higher predicted 25(OH) D levels were associated with a significant reduction in colorectal cancer-specific (P trend = 0.02) and overall mortality (P trend = 0.002). Compared with levels in the lowest quintile, participants with predicted 25(OH) D levels in the highest quintile had an adjusted HR of 0.50 (95% CI, 0.26-0.95) for cancer-specific mortality and 0.62 (95% CI, 0.42-0.93) for overall mortality. CONCLUSION : Higher predicted 25(OH) D levels after a diagnosis of colorectal cancer may be associated with improved survival. Further study of the vitamin D pathway in colorectal cancer is warranted. British Journal of Cancer (2009) 101, 916-923. doi:10.1038/sj.bjc.6605262 www.bjcancer.com Published online 18 August 2009
Description
Other Available Sources
Keywords
Terms of Use
Metadata Only